DeepMed Research

JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments

Phase 2

Active, not recruiting

Conditions: Amyotrophic Lateral Sclerosis ALS

Interventions: Drug: Astaxanthin
Drug: Protandim
Drug: MitoQ
Drug: Melatonin

First Posted Date: 2024-05-24

Last Posted Date: 2024-12-27

Lead Sponsor: Duke University

Target Recruit Count: 50

Registration Number: NCT06429059

Locations: 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Integration of Mindfulness and Acupuncture After Spine Surgery

Not Applicable

Conditions: Discetomy
Laminectomy
Single Level Spinal Fusion

Interventions: Behavioral: Mindfulness training
Other: Acupuncture
Behavioral: Enhanced education

First Posted Date: 2024-05-24

Last Posted Date: 2024-10-15

Lead Sponsor: Duke University

Target Recruit Count: 50

Registration Number: NCT06429072

Locations: 🇺🇸
Duke Sports Science Institute, Durham, North Carolina, United States

Hospital-to-Home Transitional Care Interventions (H2H-TCI) Children/Youth With Special Health Care Needs (CYSHCN)

Not Applicable

Not yet recruiting

Conditions: Transitional Care
Health Care
Comparative Effectiveness
Family Engagement
Pediatrics

Interventions: Behavioral: Focused Dose Hospital-to-Home Transitional Care Interventions
Behavioral: Extended Dose Hospital-to-Home Transitional Care Interventions

First Posted Date: 2024-05-24

Last Posted Date: 2025-02-14

Lead Sponsor: Duke University

Target Recruit Count: 480

Registration Number: NCT06428175

Neuromodulation Therapy for Task-Specific Dystonia

Not Applicable

Completed

Conditions: Isolated Focal Hand Dystonia

Interventions: Device: Repetitive transcranial magnetic stimulation

First Posted Date: 2024-05-20

Last Posted Date: 2024-05-20

Lead Sponsor: Duke University

Target Recruit Count: 12

Registration Number: NCT06422104

Locations: 🇺🇸
Duke University Health System, Durham, North Carolina, United States

VitalTraq for the Detection of CRS

Not Applicable

Recruiting

Conditions: Hematologic Malignancy

Interventions: Device: TempTraq
Device: VitalTraq

First Posted Date: 2024-05-16

Last Posted Date: 2025-04-23

Lead Sponsor: Duke University

Target Recruit Count: 32

Registration Number: NCT06415656

Locations: 🇺🇸
Duke Blood Cancer Center, Durham, North Carolina, United States

An Evaluation of a Family Counseling Intervention ("Tuko Pamoja") in Kenya

Not Applicable

Completed

Conditions: Parenting
Mental Health Issue
Adolescent - Emotional Problem
Child Behavior
Parent-Child Relations
Family Relations
Family Conflict
Adolescent Problem Behavior
Child Abuse
Marital Conflict

Interventions: Behavioral: Tuko Pamoja, "We are Together" in Kiswahili

First Posted Date: 2024-05-16

Last Posted Date: 2025-03-07

Lead Sponsor: Duke University

Target Recruit Count: 240

Registration Number: NCT06417918

Locations: 🇰🇪
Moi University, Eldoret, Kenya

RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)

Phase 2

Recruiting

Conditions: Long COVID
Long COVID-19
Sleep Disturbance

Interventions: Drug: Melantonin Placebo
Drug: Melatonin
Device: Tailored lighting (TL) Active
Device: Tailored lighting (TL) Placebo

First Posted Date: 2024-05-08

Last Posted Date: 2025-04-23

Lead Sponsor: Duke University

Target Recruit Count: 600

Registration Number: NCT06404112

Locations: 🇺🇸
All sites listed under NCT06404086, Durham, North Carolina, United States

RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)

Phase 2

Recruiting

Conditions: Long COVID-19
Long COVID
Hypersomnia

Interventions: Drug: Modafinil Placebo
Drug: Modafinil
Drug: Solriamfetol
Drug: Solriamfetol Placebo

First Posted Date: 2024-05-08

Last Posted Date: 2025-04-23

Lead Sponsor: Duke University

Target Recruit Count: 474

Registration Number: NCT06404099

Locations: 🇺🇸
All sites listed under NCT06404086, Durham, North Carolina, United States

RECOVER-SLEEP: Platform Protocol

Phase 2

Recruiting

Conditions: Long COVID
Long COVID-19
Hypersomnia
Sleep Disturbance

Interventions: Drug: Melatonin
Drug: Modafinil
Drug: Melantonin Placebo
Drug: Modafinil Placebo
Device: Tailored lighting (TL) Active
Drug: Solriamfetol
Device: Tailored lighting (TL) Placebo
Drug: Solriamfetol Placebo

First Posted Date: 2024-05-08

Last Posted Date: 2025-04-23

Lead Sponsor: Duke University

Target Recruit Count: 1074

Registration Number: NCT06404086

Locations: 🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸
University of Arizona Banner Medical Center, Tucson, Arizona, United States
🇺🇸
University of California San Francisco General Hospital, San Francisco, California, United States

and more 42 locations

RECOVER-ENERGIZE Platform Protocol_Appendix B (Structured Pacing (PEM))

Not Applicable

Recruiting

Conditions: Long Covid19
Long COVID
Long Covid-19

Interventions: Other: Usual Care
Behavioral: Structured Pacing

First Posted Date: 2024-05-08

Last Posted Date: 2024-10-17

Lead Sponsor: Duke University

Target Recruit Count: 300

Registration Number: NCT06404073

Locations: 🇺🇸
All sites listed under NCT06404047, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy